IC
CPIX icon

Ikarian Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Ikarian Capital’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Sell
553,153
-2,779
-0.5% -$10.7K 0.15% 103
2025
Q4 		$2.21M Hold
555,932
– – 0.17% 98
2025
Q3 		$1.73M Sell
555,932
-40,000
-7% -$133K 0.18% 106
2025
Q2 		$2M Sell
595,932
-144,068
-19% -$682K 0.38% 68
2025
Q1 		$3.13M Buy
+740,000
New +$3.07M 0.39% 58

Other funds holding CPIX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital's CPIX Position: Q1 2026 in Review

Ikarian Capital reduced its Cumberland Pharmaceuticals (CPIX) stake by 0.5% in Q1 2026, selling an estimated $10.7K and leaving 553,153 shares worth $1.8M. The position accounts for 0.15% of the portfolio, ranked #103.

Ikarian Capital first reported a position in CPIX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.13M in Q1 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Ikarian Capital held 553,153 shares of Cumberland Pharmaceuticals worth $1.8M as of Q1 2026.
  • Ikarian Capital sold 2,779 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $10.7K.
  • Cumberland Pharmaceuticals made up 0.15% of Ikarian Capital's portfolio in Q1 2026, its #103 holding.
  • Ikarian Capital first reported a position in Cumberland Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Ikarian Capital's Cumberland Pharmaceuticals position peaked at $3.13M in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.